<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:18:19Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7087834" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7087834</identifier>
        <datestamp>2020-03-23</datestamp>
        <setSpec>phenaturepg</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Dig Dis Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Dig. Dis. Sci</journal-id>
              <journal-title-group>
                <journal-title>Digestive Diseases and Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0163-2116</issn>
              <issn pub-type="epub">1573-2568</issn>
              <publisher>
                <publisher-name>Kluwer Academic Publishers-Plenum Publishers</publisher-name>
                <publisher-loc>New York</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7087834</article-id>
              <article-id pub-id-type="pmcid">PMC7087834</article-id>
              <article-id pub-id-type="pmc-uid">7087834</article-id>
              <article-id pub-id-type="pmid">16187176</article-id>
              <article-id pub-id-type="pmid">16187176</article-id>
              <article-id pub-id-type="publisher-id">2940</article-id>
              <article-id pub-id-type="doi">10.1007/s10620-005-2940-y</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Multiplex Cytokine Profiling of Initial Therapeutic Response in Patients with Chronic Hepatitis C Virus Infection</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wright</surname>
                    <given-names>Harlan</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alex</surname>
                    <given-names>Philip</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nguyen</surname>
                    <given-names>Thuan</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bader</surname>
                    <given-names>Teddy</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gurakar</surname>
                    <given-names>Ahmet</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sebastian</surname>
                    <given-names>Anthony</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gonzales</surname>
                    <given-names>Liberty</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wallis</surname>
                    <given-names>Gemma</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Naylor</surname>
                    <given-names>Mark</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dozmorov</surname>
                    <given-names>Igor</given-names>
                  </name>
                  <degrees>PhD, DSci</degrees>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Centola</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <address>
                    <email>centolam@omrf.ouhsc.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nour</surname>
                    <given-names>Bakr</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.266902.9</institution-id><institution-id institution-id-type="ISNI">0000000121793618</institution-id><institution>Nazhi Zuhdi Transplant Institute, Integris Baptist Medical Center, </institution><institution>University of Oklahoma Health Sciences Center, </institution></institution-wrap>Oklahoma City, Oklahoma USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.266902.9</institution-id><institution-id institution-id-type="ISNI">0000000121793618</institution-id><institution>Department of Arthritis and Immunology, Oklahoma Medical Research Foundation, </institution><institution>University of Oklahoma Health Sciences Center, </institution></institution-wrap>Oklahoma City, Oklahoma USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.266902.9</institution-id><institution-id institution-id-type="ISNI">0000000121793618</institution-id><institution>College of Medicine, </institution><institution>University of Oklahoma Health Sciences Center, </institution></institution-wrap>Oklahoma City, Oklahoma USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.274264.1</institution-id><institution-id institution-id-type="ISNI">0000000085276890</institution-id><institution>Oklahoma Medical Research Foundation, </institution></institution-wrap>825 N.E. 13th Street, MS#58, Oklahoma City, Oklahoma 73104 USA </aff>
              </contrib-group>
              <pub-date pub-type="ppub">
                <year>2005</year>
              </pub-date>
              <volume>50</volume>
              <issue>10</issue>
              <fpage>1793</fpage>
              <lpage>1803</lpage>
              <history>
                <date date-type="received">
                  <day>18</day>
                  <month>7</month>
                  <year>2004</year>
                </date>
                <date date-type="accepted">
                  <day>10</day>
                  <month>1</month>
                  <year>2005</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Springer Science + Business Media, Inc. 2005</copyright-statement>
                <license>
                  <license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p>Currently available prognostic tools are inadequate to discern the molecular basis of the heterogenic response in hepatitis C virus (HCV)-infected patients treated with the current standard of therapy. The expression and biological function of immune mediators have been shown to be critical in all phases of the immune response to HCV infection and likely therefore influence host response. Herein, a biometric multiplex serum cytokine assay was utilized to characterize the immunomodulatory effects of host response in 10 HCV patients. Serum levels of 17 cytokines were compared before and after 1 month of treatment and against controls. Overall serum cytokine levels were significantly higher in patients (<italic>P</italic> &lt; 0.05) than controls. Additionally, viral titers decreased in all patients after 1 month of therapy, as did overall serum cytokine levels in the cohort (<italic>P</italic> &lt; 0.05). To assess relationships between changes in cytokine levels and changes in viral titer, the cohort was divided into three statistically distinct subgroups based on changes in viral titers. Specific sets of cytokines decreased in each group: decreases in CCL4, interleukin (IL)-2, CXCL8, and IL-1β correlated with the greatest drops in viral titer, decreases in IL-5, granulocyte colony stimulating factor (G-CSF), and CCL4 correlated with moderate drops in viral titer, and only CCL2 correlated with the lowest drops in viral titer. Interestingly, decreases in CCL4 levels correlated with decreases in viral titers in all patients. CCL4 controls leukocyte influx and thus propagates inflammation. In conclusion, these data raise the possibility that characteristic changes in host response modulate the therapeutic response, demonstrating the prognostic power of serum cytokine profiling in chronic HCV.</p>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Key Words</title>
                <kwd>cytotoxic and humoral cytokines</kwd>
                <kwd>chemokines</kwd>
                <kwd>pegylated interferon α ribavirin</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© Springer Science + Business Media, Inc. 2005</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <back>
            <fn-group>
              <fn>
                <p>This publication was made possible by grants from Joullian Foundation, Kerr McGee Corporation, Dr. Henry Freeds Foundation, Samuel Roberts Noble Foundation, and E. L. &amp; Thelma Gaylord Foundation and Grants P20 RR 017703, R21-AR-48378, NIH 1 P20 RR15577, and NIH 1 P20 RR16478 from the National Institutes of Health.</p>
              </fn>
            </fn-group>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>World Health Organization</collab>
                  </person-group>
                  <article-title>Hepatitis C</article-title>
                  <source>Wkly Epidemiol Rec</source>
                  <year>1997</year>
                  <volume>72</volume>
                  <fpage>65</fpage>
                  <lpage>69</lpage>
                  <pub-id pub-id-type="pmid">9115857</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alter</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Kruszon-Moran</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Nainan</surname>
                      <given-names>OV</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</article-title>
                  <source>N Engl J Med</source>
                  <year>1999</year>
                  <volume>341</volume>
                  <fpage>556</fpage>
                  <lpage>562</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM199908193410802</pub-id>
                  <?supplied-pmid 10451460?>
                  <pub-id pub-id-type="pmid">10451460</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alter</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Epidemiology of hepatitis C</article-title>
                  <source>Hepatology</source>
                  <year>1997</year>
                  <volume>26</volume>
                  <fpage>62S</fpage>
                  <lpage>65S</lpage>
                  <pub-id pub-id-type="doi">10.1002/hep.510260711</pub-id>
                  <?supplied-pmid 9305666?>
                  <pub-id pub-id-type="pmid">9305666</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoofnagle</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <article-title>Course and outcome of hepatitis C</article-title>
                  <source>Hepatology</source>
                  <year>2002</year>
                  <volume>36</volume>
                  <issue>5; Suppl 1</issue>
                  <fpage>S21</fpage>
                  <lpage>S29</lpage>
                  <pub-id pub-id-type="doi">10.1053/jhep.2002.36227</pub-id>
                  <?supplied-pmid 12407573?>
                  <pub-id pub-id-type="pmid">12407573</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fattovich</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Giustina</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Degos</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Morbidity and mortality in compensated cirrhosis type C a retrospective follow-up study of 384 patients</article-title>
                  <source>Gastroenterology</source>
                  <year>1997</year>
                  <volume>112</volume>
                  <fpage>463</fpage>
                  <lpage>472</lpage>
                  <pub-id pub-id-type="doi">10.1053/gast.1997.v112.pm9024300</pub-id>
                  <?supplied-pmid 9024300?>
                  <pub-id pub-id-type="pmid">9024300</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bruix</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Barrera</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Calvet</surname>
                      <given-names>X</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis</article-title>
                  <source>Lancet</source>
                  <year>1989</year>
                  <volume>2</volume>
                  <fpage>1004</fpage>
                  <lpage>1006</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(89)91015-5</pub-id>
                  <?supplied-pmid 2572739?>
                  <pub-id pub-id-type="pmid">2572739</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Di Bisceglie</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>LH</given-names>
                    </name>
                    <name>
                      <surname>Lotze</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Hoofnagle</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <article-title>Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection</article-title>
                  <source>J Clin Gastroenterol</source>
                  <year>1994</year>
                  <volume>19</volume>
                  <fpage>222</fpage>
                  <lpage>226</lpage>
                  <?supplied-pmid 7528758?>
                  <pub-id pub-id-type="pmid">7528758</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cummings</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>West</surname>
                      <given-names>ES</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: a meta- analysis of randomized trials</article-title>
                  <source>JAMA</source>
                  <year>2001</year>
                  <volume>285</volume>
                  <fpage>193</fpage>
                  <lpage>199</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.285.2.193</pub-id>
                  <?supplied-pmid 11176813?>
                  <pub-id pub-id-type="pmid">11176813</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McHutchison</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Gordon</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Schiff</surname>
                      <given-names>ER</given-names>
                    </name>
                  </person-group>
                  <article-title>Interferon-α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group</article-title>
                  <source>N Engl J Med</source>
                  <year>1998</year>
                  <volume>339</volume>
                  <fpage>1485</fpage>
                  <lpage>1492</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM199811193392101</pub-id>
                  <?supplied-pmid 9819446?>
                  <pub-id pub-id-type="pmid">9819446</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>August-Jorg</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Borovicka</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Dufour</surname>
                      <given-names>JF</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Swiss Association for the Study of the Liver: Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C</article-title>
                  <source>Swiss Med Wkly</source>
                  <year>2003</year>
                  <volume>23</volume>
                  <issue>33–34</issue>
                  <fpage>455</fpage>
                  <lpage>460</lpage>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McHutchison</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Manns</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Garaud</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Albrecht</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Adherence to therapy enhances sustained response in chronic hepatitis C patients receiving peginterferon-α 2b plus ribavirin</article-title>
                  <source>Gastroenterology</source>
                  <year>2002</year>
                  <volume>123</volume>
                  <fpage>1061</fpage>
                  <lpage>1069</lpage>
                  <pub-id pub-id-type="doi">10.1053/gast.2002.35950</pub-id>
                  <?supplied-pmid 12360468?>
                  <pub-id pub-id-type="pmid">12360468</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fried</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Shiffman</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Reddy</surname>
                      <given-names>RK</given-names>
                    </name>
                  </person-group>
                  <article-title>Pegylated (40 kDa) interferon-α-2a (PEGASYS (R)) in combination with ribavirin: efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study</article-title>
                  <source>N Engl J Med</source>
                  <year>2002</year>
                  <volume>347</volume>
                  <fpage>975</fpage>
                  <lpage>982</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa020047</pub-id>
                  <?supplied-pmid 12324553?>
                  <pub-id pub-id-type="pmid">12324553</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mihm</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Fayyazi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hartmann</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Ramadori</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype</article-title>
                  <source>Hepatology</source>
                  <year>1997</year>
                  <volume>25</volume>
                  <issue>3</issue>
                  <fpage>735</fpage>
                  <lpage>739</lpage>
                  <pub-id pub-id-type="doi">10.1002/hep.510250340</pub-id>
                  <?supplied-pmid 9049227?>
                  <pub-id pub-id-type="pmid">9049227</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Batts</surname>
                      <given-names>KP</given-names>
                    </name>
                    <name>
                      <surname>Ludwig</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic hepatitis. An update on terminology and reporting</article-title>
                  <source>Am J Surg Pathol</source>
                  <year>1995</year>
                  <volume>19</volume>
                  <issue>12</issue>
                  <fpage>1409</fpage>
                  <lpage>1417</lpage>
                  <?supplied-pmid 7503362?>
                  <pub-id pub-id-type="pmid">7503362</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bertoletti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ferrari</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Kinetics of the immune response during HBV and HCV infection</article-title>
                  <source>Hepatology</source>
                  <year>2003</year>
                  <volume>38</volume>
                  <issue>1</issue>
                  <fpage>4</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1053/jhep.2003.50310</pub-id>
                  <?supplied-pmid 12829979?>
                  <pub-id pub-id-type="pmid">12829979</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tsai</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Liaw</surname>
                      <given-names>YF</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>CY</given-names>
                    </name>
                    <name>
                      <surname>Kuo</surname>
                      <given-names>GC</given-names>
                    </name>
                  </person-group>
                  <article-title>Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity</article-title>
                  <source>Hepatology</source>
                  <year>1997</year>
                  <volume>25</volume>
                  <fpage>449</fpage>
                  <lpage>458</lpage>
                  <?supplied-pmid 9021963?>
                  <pub-id pub-id-type="pmid">9021963</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Woitas</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Lechmann</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jung</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Kaiser</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Sauerbruch</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Spengler</surname>
                      <given-names>U</given-names>
                    </name>
                  </person-group>
                  <article-title>CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes</article-title>
                  <source>J Immunol</source>
                  <year>1997</year>
                  <volume>159</volume>
                  <fpage>1012</fpage>
                  <lpage>1018</lpage>
                  <?supplied-pmid 9218624?>
                  <pub-id pub-id-type="pmid">9218624</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Napoli</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bishop</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>McGuinness</surname>
                      <given-names>PH</given-names>
                    </name>
                    <name>
                      <surname>Painter</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>McCaughan</surname>
                      <given-names>GW</given-names>
                    </name>
                  </person-group>
                  <article-title>Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines</article-title>
                  <source>Hepatology</source>
                  <year>1996</year>
                  <volume>24</volume>
                  <fpage>759</fpage>
                  <lpage>765</lpage>
                  <?supplied-pmid 8855173?>
                  <pub-id pub-id-type="pmid">8855173</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fan</surname>
                      <given-names>XG</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>WE</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>CZ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection</article-title>
                  <source>Mediators Inflamm</source>
                  <year>1998</year>
                  <volume>7</volume>
                  <issue>4</issue>
                  <fpage>295</fpage>
                  <lpage>297</lpage>
                  <pub-id pub-id-type="doi">10.1080/09629359890992</pub-id>
                  <?supplied-pmid 9792341?>
                  <pub-id pub-id-type="pmid">9792341</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <mixed-citation publication-type="other">Oxo Chemie Ag Initiates Macrokine Phase 2 Clinical Trials. Worldwide Biotech, August 2000</mixed-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Simmonds</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Alberti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Alter</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A proposed system for the nomenclature of hepatitis C viral genotypes</article-title>
                  <source>Hepatology</source>
                  <year>1994</year>
                  <volume>19</volume>
                  <fpage>1321</fpage>
                  <lpage>1324</lpage>
                  <pub-id pub-id-type="doi">10.1016/0270-9139(94)90887-7</pub-id>
                  <?supplied-pmid 8175159?>
                  <pub-id pub-id-type="pmid">8175159</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Szodoray</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Alex</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Brun</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Centola</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jonsson</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Description of circulating cytokines in Sjögren's syndrome using a multiplex cytokine array system</article-title>
                  <source>Scand J Immunol</source>
                  <year>2004</year>
                  <volume>59</volume>
                  <issue>6</issue>
                  <fpage>592</fpage>
                  <lpage>599</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.0300-9475.2004.01432.x</pub-id>
                  <?supplied-pmid 15182255?>
                  <pub-id pub-id-type="pmid">15182255</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <mixed-citation publication-type="other">Chappell C, Wallis G, Alex P, <italic>et al</italic>.: Distinct immunopathological disease profiles of the spondyloarthropathies. FASEB J 18(3; Suppl), 2004 (abstr)</mixed-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alex</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Wallis</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Szodoray</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A powerful prognostic tool to predict treatment outcome in rheumatoid arthritis</article-title>
                  <source>Arth Rheum</source>
                  <year>2003</year>
                  <volume>29</volume>
                  <issue>9; Suppl</issue>
                  <fpage>129</fpage>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chappell</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Scofield</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wallis</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Kurien</surname>
                      <given-names>BT</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>RI</given-names>
                    </name>
                    <name>
                      <surname>Centola</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <article-title>Distinct molecular immunopathological disease profiles of ankylosing spondylitis</article-title>
                  <source>Arth Rheum</source>
                  <year>2003</year>
                  <volume>29</volume>
                  <issue>9; Suppl</issue>
                  <fpage>1560</fpage>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dozmorov</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Centola</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>An associative analysis of gene expression array data</article-title>
                  <source>Bioinformatics</source>
                  <year>2003</year>
                  <volume>22</volume>
                  <issue>2</issue>
                  <fpage>204</fpage>
                  <lpage>211</lpage>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dozmorov</surname>
                      <given-names>IM</given-names>
                    </name>
                    <name>
                      <surname>Saban</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Knowlton</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Centola</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Saban</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Connective molecular pathways of experimental bladder inflammation</article-title>
                  <source>Physiol Genom</source>
                  <year>2003</year>
                  <volume>15</volume>
                  <fpage>209</fpage>
                  <lpage>222</lpage>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>EASL International Consensus Conference on Hepatitis C. Paris, 26-27 February</collab>
                  </person-group>
                  <article-title>Consensus statement [no authors listed]</article-title>
                  <source>J Hepatol</source>
                  <year>1999</year>
                  <volume>31</volume>
                  <issue>Suppl 1</issue>
                  <fpage>3</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="pmid">10622553</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heathcote</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Shiffman</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Cooksley</surname>
                      <given-names>WG</given-names>
                    </name>
                  </person-group>
                  <article-title>Peginterferon-α-2a in patients with chronic hepatitis C and cirrhosis</article-title>
                  <source>N Engl J Med</source>
                  <year>2000</year>
                  <volume>343</volume>
                  <fpage>1673</fpage>
                  <lpage>1680</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM200012073432302</pub-id>
                  <?supplied-pmid 11106716?>
                  <pub-id pub-id-type="pmid">11106716</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davis</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Esteban-Mur</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rustgi</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Interferon-α-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group</article-title>
                  <source>N Engl J Med</source>
                  <year>1998</year>
                  <volume>339</volume>
                  <fpage>1493</fpage>
                  <lpage>1499</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM199811193392102</pub-id>
                  <?supplied-pmid 9819447?>
                  <pub-id pub-id-type="pmid">9819447</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Olivieri</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Palazzi</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Padula</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Hepatitis C virus and arthritis</article-title>
                  <source>Rheum Dis Clin North Am</source>
                  <year>2003</year>
                  <volume>29</volume>
                  <issue>1</issue>
                  <fpage>111</fpage>
                  <lpage>122</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0889-857X(02)00097-2</pub-id>
                  <?supplied-pmid 12635503?>
                  <pub-id pub-id-type="pmid">12635503</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aceti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Taliani</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Sorice</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Amendolea</surname>
                      <given-names>MA</given-names>
                    </name>
                  </person-group>
                  <article-title>HCV and Sjogren's syndrome</article-title>
                  <source>Lancet</source>
                  <year>1992</year>
                  <volume>6</volume>
                  <issue>8806</issue>
                  <fpage>1425</fpage>
                  <lpage>1426</lpage>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hirohata</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Inoue</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Ito</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection</article-title>
                  <source>Intern Med</source>
                  <year>1992</year>
                  <volume>31</volume>
                  <issue>4</issue>
                  <fpage>493</fpage>
                  <lpage>495</lpage>
                  <?supplied-pmid 1633356?>
                  <pub-id pub-id-type="pmid">1633356</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Siegel</surname>
                      <given-names>LB</given-names>
                    </name>
                    <name>
                      <surname>Cohn</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Nashel</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Rheumatic manifestations of hepatitis C infection</article-title>
                  <source>Semin Arth Rheum</source>
                  <year>1993</year>
                  <volume>23</volume>
                  <issue>3</issue>
                  <fpage>149</fpage>
                  <lpage>154</lpage>
                  <pub-id pub-id-type="pmid">8122117</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shields</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Morland</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Salmon</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hubscher</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Adams</surname>
                      <given-names>DH</given-names>
                    </name>
                  </person-group>
                  <article-title>Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver</article-title>
                  <source>J Immunol</source>
                  <year>1999</year>
                  <volume>163</volume>
                  <fpage>6236</fpage>
                  <lpage>6243</lpage>
                  <?supplied-pmid 10570316?>
                  <pub-id pub-id-type="pmid">10570316</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murai</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Yoneyama</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Harada</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease</article-title>
                  <source>J Clin Invest</source>
                  <year>1999</year>
                  <volume>104</volume>
                  <fpage>49</fpage>
                  <lpage>57</lpage>
                  <?supplied-pmid 10393698?>
                  <pub-id pub-id-type="pmid">10393698</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Westermann</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bode</surname>
                      <given-names>U</given-names>
                    </name>
                  </person-group>
                  <article-title>Distribution of activated T cells migrating through the body: a matter of life and death</article-title>
                  <source>Immunol Today</source>
                  <year>1999</year>
                  <volume>20</volume>
                  <fpage>302</fpage>
                  <lpage>306</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0167-5699(99)01474-7</pub-id>
                  <?supplied-pmid 10379047?>
                  <pub-id pub-id-type="pmid">10379047</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bigger</surname>
                      <given-names>CB</given-names>
                    </name>
                    <name>
                      <surname>Guerra</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Brasky</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Beard</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Luxon</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Lemon</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Lanford</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <article-title>Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees</article-title>
                  <source>J Virol</source>
                  <year>2004</year>
                  <volume>78</volume>
                  <issue>24</issue>
                  <fpage>13779</fpage>
                  <lpage>13792</lpage>
                  <pub-id pub-id-type="doi">10.1128/JVI.78.24.13779-13792.2004</pub-id>
                  <?supplied-pmid 15564486?>
                  <pub-id pub-id-type="pmid">15564486</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lichterfeld</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Leifeld</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Nischalke</surname>
                      <given-names>HD</given-names>
                    </name>
                    <name>
                      <surname>Rockstroh</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Hess</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Sauerbruch</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Spengler</surname>
                      <given-names>U</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection</article-title>
                  <source>J Infect Dis</source>
                  <year>2002</year>
                  <volume>15</volume>
                  <issue>12</issue>
                  <fpage>1803</fpage>
                  <lpage>1807</lpage>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lau</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Yam</surname>
                      <given-names>LY</given-names>
                    </name>
                    <name>
                      <surname>Cheung</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Poon</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Yung</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Yuen</surname>
                      <given-names>KY</given-names>
                    </name>
                  </person-group>
                  <article-title>Development of a standard treatment protocol for severe acute respiratory syndrome</article-title>
                  <source>Lancet</source>
                  <year>2003</year>
                  <volume>10</volume>
                  <issue>9369</issue>
                  <fpage>1615</fpage>
                  <lpage>1617</lpage>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
